Information Provided By:
Fly News Breaks for October 9, 2019
WAT
Oct 9, 2019 | 06:43 EDT
Barclays analyst Jack Meehan downgraded Waters to Underweight from Equal Weight with a price target of $195, down from $210. The analyst says that as leading indicators of the macro environment continue to weaken, he sees risk to the outlook for Waters' Industrial sales exposure. Additionally, he's cautious that the company's growth with pharma sponsors will continue to lag peers. Waters leadership in liquid chromatographycreates "outsized" exposure to small molecule applications, where generic consolidation has led investment to lag relative to large molecule applications, Meehan tells investors in a research note.
News For WAT From the Last 2 Days
There are no results for your query WAT